Period of time： 2012年5期
Publisher： Adis International
Founded in： 2001
Total resources： 72
ISSN： 1175-3277
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
American Journal of Cardiovascular Drugs,volume 3,issue 5
Menu
Hyperuricemia and Adverse Outcomes in Cardiovascular Disease: Potential for Therapeutic Intervention
By Gavin A.R., Struthers A.D. in (2003)
American Journal of Cardiovascular Drugs,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-01 , pp.
Access to resources
Recommend
Clinical Potential of Advanced Glycation End-Product Inhibitors in Diabetes Mellitus
By Menè P., Festuccia F., Pugliese F. in (2003)
American Journal of Cardiovascular Drugs,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-01 , pp.Immunosuppressive Therapy for Heart Failure: A Guide to Patient Selection
By Nowalany-Kozielska E. in (2003)
American Journal of Cardiovascular Drugs,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-01 , pp.Smoking Cessation for Patients with Cardiovascular Disease: What is the Best Approach?
By Joseph A.M., Fu S.S. in (2003)
American Journal of Cardiovascular Drugs,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-01 , pp.By Waugh J., Keating G.M. in (2003)
American Journal of Cardiovascular Drugs,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-01 , pp.Losartan: A Viewpoint by Sverre E. Kjeldsen
American Journal of Cardiovascular Drugs,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-01 , pp.By Ibbotson T., McGavin J.K., Goa K.L. in (2003)
American Journal of Cardiovascular Drugs,volume 3,issue 5 , Vol. 3, Iss. 5, 2003-01 , pp.